News
US lawmakers take FDA to task over rare diseases record
Lawmakers and patient advocates in the US are concerned that the FDA's regulation of rare disease therapies has been inconsistent and overly cautious.
R&D
How innovative trial approaches are advancing rare disease r...
Innovative trial designs that harness data augmentation, RWD, and the power of AI are enabling a new era of rare disease research.
News
Generate's IPO gets over the line, raising $400m
AI-powered drug developer Generate Biomedicine completes a $400m IPO, the largest for biotech on the Nasdaq so far this year.
R&D
Agentic AI and the human element: Building trustworthy autom...
The future of clinical trials isn’t about replacing people. It’s about empowering them with smarter tools.
News
Boehringer bets up to $500m on Sitryx immunology programme
Boehringer Ingelheim's partnership with Sitryx is focused on a family of small-molecule drugs for autoimmune and inflammatory diseases.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
